Better birth outcomes start before diabetes meets pregnancy
Maternal diabetes and congenital anomalies are closely connected, particularly when hyperglycaemia is present during the earliest weeks of pregnancy. For women with type 1 or type 2 diabetes, structural development may already be affected before a pregnancy test turns positive. Gestational diabetes usually develops later, but earlier metabolic dysfunction, obesity and a previous affected pregnancy can still increase risk. Reducing congenital malformations therefore depends on care that begins before conception rather than after the first antenatal appointment.
Preconception care offers time to review glycaemic control, medications, nutrition, folic acid use and reproductive plans. It also creates an opportunity to identify social and geographic barriers that might interrupt treatment. In Australia, that means connecting general practice, endocrinology, obstetrics, dietetics, pharmacy support and Aboriginal health services. The central challenge is closing preconception care gaps while keeping advice practical, culturally safe and accessible to women living outside major metropolitan centres.
Why the highest-risk weeks happen before conception
The heart and neural tube form during organogenesis, roughly three to eight weeks after fertilisation. This period often overlaps with the time a woman considers a missed period or waits for a home pregnancy test to become reliable. If diabetes is poorly controlled during this window, elevated glucose and associated metabolic changes can disrupt embryonic development. The result may be a congenital malformation even when later pregnancy care is intensive and well coordinated.
Risks include cardiac defects, neural tube defects and caudal regression syndrome, although the likelihood and pattern vary with the type and severity of maternal diabetes. Oxidative stress, altered mitochondrial function and changes in gene expression are among the proposed mechanisms. Hyperglycaemia-related embryopathy is therefore a useful description of the process, while the exact contribution of each biological factor remains under investigation. Congenital anomalies occur more often in pregnancies complicated by pre-existing diabetes, especially when early HbA1c is elevated.
The effects of diabetes during pregnancy extend beyond structural anomalies. Maternal complications can include hypertensive disorders, pre-eclampsia, macrosomia and caesarean birth, while babies may experience neonatal hypoglycaemia, respiratory difficulty or admission to neonatal intensive care. These outcomes shape the health of mothers and infants for years. Addressing them requires a shift from treating pregnancy as the point at which risk begins to treating preparation for pregnancy as a distinct phase of preventive care.
Where Australian care pathways fragment
In Melbourne, Sydney, Adelaide and other cities, many tertiary hospitals provide dedicated diabetes-in-pregnancy or maternal-fetal medicine services. Access varies, however, because women may need separate referrals to a general practitioner, endocrinologist, obstetrician, dietitian, pharmacist or diabetes educator. A woman may optimise glucose with one clinician, receive folate advice from another and encounter inconsistent medication guidance during early pregnancy. Private insurance, public hospital demand and local waiting lists can add further friction.
Rural and remote women face different barriers. Communities across northern and central Australia may be hours from a tertiary obstetric unit, while Aboriginal and Torres Strait Islander women can experience inequitable access arising from remoteness, workforce shortages, transport costs and the effects of intergenerational trauma. Aboriginal Medical Services, community-controlled health organisations and telehealth can provide culturally safe continuity. Medicare-subsidised general practice, the National Diabetes Services Scheme and PBS-listed medicines help with affordability, but a referral pathway and local follow-up still need to exist.
A side-by-side view clarifies where care must change:
| Care element | Before conception | After pregnancy is recognised |
|---|---|---|
| Glycaemia review | Review glucose records, HbA1c, hypoglycaemia and treatment goals | Arrange prompt specialist review without interrupting essential insulin or other therapy |
| Folic acid | Begin clinician-guided supplementation for people at increased risk | Start promptly if it has not already been taken, while recognising that later use cannot reverse earlier exposure |
| Medication review | Adjust unsuitable medicines under supervision and maintain reliable contraception | Reassess every medicine because requirements change during pregnancy |
| Care coordination | Establish a shared plan involving primary care and specialist services | Link general practice, endocrinology, obstetrics and maternity services through one coordinated pathway |
| Follow-up | Address nutrition, access, transport, cost and health literacy before pregnancy | Monitor maternal and fetal wellbeing closely, including fetal growth and congenital anomaly assessment |
What preconception care should change
A useful preconception assessment looks beyond the latest HbA1c result. It considers recent glucose patterns, severe hypoglycaemia, blood pressure, kidney function, retinopathy, neuropathy and foot health. The clinician also reviews medicines with pregnancy-specific risks, vaccination status, smoking, alcohol use, nutrition and weight goals. Family history, previous pregnancy outcomes and the circumstances of earlier births can reveal problems that were never formally identified. An individualised HbA1c target is more meaningful than applying the same figure to every woman.
International collaboration has long accelerated progress in perinatal medicine. The archived FAOPS 2020 programme from the cancelled Tokyo meeting illustrates the value of bringing together researchers and clinicians concerned with diabetes, fetal growth and congenital outcomes. Its cancellation during the COVID-19 pandemic also demonstrated the need for adaptable education and shared protocols. Australian services can draw on international evidence while adapting it to local pathways, workforce roles and the needs of rural, remote and culturally diverse populations.
Care planning should support women without judgement or unrealistic timelines. Achieving a safer metabolic environment can take several months, but some interventions, including folate supplementation, smoking cessation, vaccination and medicine review, can begin immediately. Where continuous glucose monitoring or additional testing is appropriate, access through the National Diabetes Services Scheme may reduce out-of-pocket costs. Women who work irregular hours, care for family members or live remotely may benefit from telehealth, downloadable records and practical advice about glucose monitoring and hypoglycaemia prevention.
A practical pathway for women and families
A dedicated preconception service can bring multiple assessments into one coordinated plan. A general practitioner can initiate the process, supported by an endocrinologist, obstetrician, dietitian, diabetes educator and pharmacist as needed. The first visit should include contraception advice, a review of pregnancy goals and a clear explanation of how maternal glucose affects fetal development. Where a woman does not plan to conceive soon, her diabetes care should continue without an expectation that every consultation will focus on pregnancy.
Broader family health matters during this planning stage. Erectile dysfunction can affect confidence, relationships and readiness for conception, and medicines bought from an unregulated online sildenafil seller may have uncertain ingredients, strengths or interactions. A pharmacist or clinician can provide safer alternatives and discuss the effects of other medicines. This approach treats sexual health as part of healthy conception planning rather than as an isolated issue.
Several practical actions can reduce the risk of an unplanned pregnancy occurring before care is ready:
- Begin a review while contraception continues, then agree on an appropriate timing and contraception plan for when the clinical team considers readiness.
- For pre-existing diabetes, ask a clinician about the Australian recommendation for 5 mg folic acid each day before conception and through the early pregnancy period.
- Request a written plan covering glucose targets, medicine changes, monitoring, sick-day management and who to contact when pregnancy is suspected.
- Establish links with a maternity service before conception, including options for rural travel, telehealth, Aboriginal health support and culturally safe care.
Move from planning to prevention
A positive pregnancy test should never be treated as the first opportunity to discuss diabetes, even when a pregnancy was planned. Organogenesis may already have occurred, and sudden changes to insulin or other treatment can create additional danger. An early review can still optimise glucose, identify missed supplements or medicines, assess fetal growth and provide appropriate screening. It also protects the mother by reducing the likelihood of severe hypoglycaemia, hypertensive complications and difficult birth.
Women with diabetes who may become pregnant can act now by booking an appointment with a general practitioner and bringing their medication list, glucose records and previous maternity notes. A referral to a diabetes-in-pregnancy clinic, endocrinologist, dietitian or obstetrician can follow from that consultation. Healthdirect’s nurse line, 1800 022 222, can provide guidance about local services, while an Aboriginal Health Practitioner or authorised community health worker may offer additional support where appropriate.
Preconception care cannot eliminate every fetal risk, but it can make a substantial difference before the most vulnerable stage of development begins. Early advice, coordinated follow-up and accessible Australian services give women and families a stronger start to every pregnancy.
